Avricore Health Inc. AVCRF
0.00 USD 0.00 (+0.00%)
At closeNov 10, 2026, 4:00 PM EST
0.037 Day range 0.037
0.0008 52-week range 0.07868
- YTD
- -98.32%
- 1 year
- -97.98%
News
globenewswire.com HealthTab™ and HeartEye Open New Referral Pathway into Community Pharmacy VANCOUVER, British Columbia, Oct. 08, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) is pleased to announce that its wholly owned subsidiary, HealthTab Ltd.…
globenewswire.com HealthTab™ Programme Expands Nationally Across England VANCOUVER, British Columbia, Sept. 01, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) is pleased to announce that NHS England has confirmed the national expansion of the Barts Health…
globenewswire.com Avricore Grants Options VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) today announces that the Company's board of directors has approved the granting of stock options (the…
globenewswire.com HealthTab™ Enters Multi-Year Collaboration Agreement with Abbott for Point-of-Care Testing Across the UK VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) is pleased to announce that its wholly-owned subsidiary, HealthTab Ltd, has entered into a formal…
globenewswire.com Avricore Health Closes $1.254 Million Financing VANCOUVER, British Columbia, June 17, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces that, further to its news release dated May 20, 2026, the…
globenewswire.com Avricore Health Announces $1.25 Million Financing VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) announces a non-brokered private placement of up to 25,000,000 units…
globenewswire.com Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) announces HealthTab™ has now screened more than 3,500 patients in…
globenewswire.com HealthTab™ to Expand Across North East London VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) today announced the planned expansion of its HealthTab™ platform across…
globenewswire.com Avricore Grants Options VANCOUVER, British Columbia, June 14, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) today announces that the Company's board of directors has approved the…
globenewswire.com Avricore Appoints Rodger Seccombe as CEO VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) is pleased to report the appointment of Rodger Seccombe as CEO of the…
globenewswire.com AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) reports on its result for the first quarter of 2025 and its progress…
globenewswire.com AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track VANCOUVER, British Columbia, May 01, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) reports on its year end 2024 and In the year ended December 31, 2024…
globenewswire.com HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) today announced its successful integration of…
globenewswire.com Avricore Health Corporate Update: Effective Plan, Resources Result in Success VANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) reports on its third quarter results for 2024 where the Company…
globenewswire.com Avricore Health Refocuses Strategy to Unlock Growth Potential VANCOUVER, British Columbia, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSX-V: AVCR) ("Avricore" or the "Company"), a leader in pharmacy-based point-of-care testing solutions, today…
globenewswire.com Avricore Health Recognized in Deloitte's 2024 Technology Fast 50™ Companies to Watch VANCOUVER, British Columbia, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSX-V: AVCR), a leader in pharmacy-based health technology solutions, proudly announces its placement in Deloitte…
globenewswire.com Avricore Grants Options VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) today announces that the Company's board of directors has approved the…
globenewswire.com Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability VANCOUVER, British Columbia, Aug. 29, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) reports on its mid-year results for 2024 demonstrating the Company's…
proactiveinvestors.com Avricore Health passes major milestone as it moves into profitability Avricore Health (TSX-V:AVCR, OTC:AVCRF) passed a significant milestone in its commercial journey as it reported its first-ever profit in the three months ended March 31, posting $168,537 of…
proactiveinvestors.com Avricore Health announces strong full-year financial and strategic growth Avricore Health (TSX-V:AVCR, OTC:AVCRF) Inc. increased both revenue and profitability in 2023, with the former nearly doubling to $3.5 million and gross profit increasing by 163% to $1.2 million.